Merck-Orion Deal to Accelerate Therapy for Advanced Prostate Cancer by admin_63069 | Jul 30, 2022 | Articles of Interest Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer.
